Online Mindfulness-Based Eating Awareness Training for obesity

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2020
INTERVENTION: Mindfulness‐Based Eating Awareness Training CONDITION: Obesity PRIMARY OUTCOME: Mean Change from Baseline of Hunger Score in TFEQ subscale (Time Frame: Baseline, 14visits and after 6 months (Self‐Reported Questionnaire) SECONDARY OUTCOME: Mean Change from Baseline to 14 visits, and after 6 months; (1) Body Mass Index; (2)Weight loss rate; (3)Three‐Factor Eating Questionnaire(Total Score, Disinhibition subscale, Cognitive Restraint subscale); (4)Beck Depression Inventory; (5)State‐Trait Anxiety Inventory; (6)Rosenberg Self‐Esteem Scale; (7)Barratt Impulsiveness Scale.; (8)Positive and Negative Affect Schedule.; (9)Binge Eating Scale.; (10)Five Facet Mindfulness Questionnaire.; (11)Mindfulness Attention Awareness Scale.; (12)Self‐Compassion Scale.; (13)Exercise frequency(Meditation,Yoga,Number of steps); (14)Drug name of concomitant drug and daily dose.; ; Mean Change from Baseline to 14 visits.; (15)Serum protein(Leptin, Adiponectin, BDNF, Cortisol); ; Mean Change from Baseline to 6 months later.; Changes in brain function and structure due to resting images, diffusion tensor images, and morphological brain images; ; Presence or absence of adverse events INCLUSION CRITERIA: 1)Primary diagnosis of Obesity with a BMI of 30 or higher 2)The age between 18 to 65. 3)Patients with full consent of participation in the study. 4)Possible to communicate in Japanese. 5)Patients who have an internet environment at home and have a personal computer or tablet device. 6)No addition of weight loss drug or appetite suppressant during the study 7)Possible to understand Mindfulness‐Based Eating Awareness Training and have mental and physical condition that can be participate the session for at least 6 months. 8)If Obesity is primary diagnosed, patients with Depressive Disorder and Anxiety Disorder will not be excluded from the study. 9)Patients who agree not to use weight loss drugs (Sanorex) for about 6 months until the end of the study. 10)Patients who agree not to undergo Bariatric surgery for about 6 months until the end of the study
Epistemonikos ID: b3cae372c3f8059414de6d845f625c98b50ed2ad
First added on: Aug 24, 2024